What are the dosing instructions and contraindications for Bromfed DM (bromhexine, dextromethorphan, pseudoephedrine) in adults, adolescents, and children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Bromfed DM: Dosing and Contraindications

Critical Safety Warning

Bromfed DM is a combination product containing brompheniramine (antihistamine), dextromethorphan (cough suppressant), and pseudoephedrine (decongestant), and should be dosed according to the dextromethorphan component with careful attention to avoid exceeding safe limits of all three ingredients.


Dosing Recommendations by Age Group

Adults and Adolescents (≥12 years)

  • Dextromethorphan dosing should be 30-60 mg per dose for effective cough suppression, as doses of 10-15 mg found in many OTC products are sub-therapeutic 1
  • Maximum cough-reflex suppression occurs at 60 mg of dextromethorphan, with total daily dose not exceeding 120 mg/day 1
  • Dosing interval should be every 6-8 hours as needed for cough 1
  • In adolescents aged 12-17 years, a 30 mg dextromethorphan dose has been studied and found safe 2

Children (6-11 years)

  • Age-weight based dosing schedules should be used, with dextromethorphan doses ranging from 7.5-24.75 mg depending on weight 2
  • Multiple-dose administration over 4 days has been shown safe and effective in this age group 3
  • Objective evidence demonstrates 21-25% reduction in cough frequency with dextromethorphan compared to placebo in children aged 6-11 years 3

Young Children (2-5 years)

  • Age-weight dosing schedules apply, with dextromethorphan doses in the range of 7.5 mg and above based on weight 2
  • Single doses have been demonstrated safe in this age group 2

Infants and Children <2 years

  • Extreme caution required: A 23-month-old child experienced life-threatening toxicity requiring intubation after a 71.4 mg/kg dextromethorphan ingestion 4
  • Doses exceeding 5-7.5 mg/kg require emergency department referral 5

Key Contraindications and Warnings

Absolute Contraindications

  • Concomitant use with monoamine oxidase inhibitors (MAOIs) or within 14 days of MAOI discontinuation due to risk of serotonin syndrome 5, 6
  • Patients taking selective serotonin reuptake inhibitors (SSRIs) require close monitoring for serotonin syndrome with 2-hour follow-up for 8 hours 5

Clinical Situations Where Cough Suppression is Harmful

  • Productive cough with pneumonia or bacterial superinfection should not be suppressed, as cough clearance is therapeutically important 1
  • Patients with bronchiectasis require airway clearance rather than cough suppression 7

Dosing Pitfalls to Avoid

  • Do not use sub-therapeutic dextromethorphan doses (10-15 mg) as they are inadequate for cough suppression 1
  • Exercise extreme caution with combination products containing acetaminophen to avoid exceeding safe acetaminophen limits when dosing for adequate dextromethorphan effect 1
  • The pseudoephedrine component carries cardiovascular risks in patients with hypertension, heart disease, or hyperthyroidism 8

Overdose Management

Referral Thresholds

  • Any ingestion >7.5 mg/kg of dextromethorphan requires emergency department evaluation 5
  • Ingestions of 5-7.5 mg/kg require poison center follow-up every 2 hours for 4 hours 5
  • All intentional ingestions, abuse, or suspected malicious intent require emergency department referral 5

Toxic Effects

  • Blood dextromethorphan concentrations exceeding 100 ng/mL can be toxic in young children (therapeutic range 10-40 ng/mL) 4
  • Symptoms include altered mental status, mydriasis, nystagmus, opisthotonos, tachycardia, and hypertension 4
  • Naloxone can be considered for sedation or respiratory depression in usual opioid overdose doses 5
  • Benzodiazepines should be used for seizures and hyperthermia >104°F associated with serotonin syndrome 5

Home Management

  • Do not induce emesis 5
  • Do not administer activated charcoal at home 5
  • Asymptomatic patients >4 hours post-ingestion can be observed at home 5

Clinical Context and Appropriate Use

When Bromfed DM is Appropriate

  • Nonproductive dry cough where dextromethorphan is first-line treatment 7
  • Nocturnal cough disrupting sleep, where the antihistamine component (brompheniramine) provides additional sedative benefit 1, 7
  • Upper respiratory infections when simple remedies (honey-lemon mixture) have failed 1, 7

When to Avoid Bromfed DM

  • Viral URI cough should first be treated with honey-lemon mixture, adequate hydration, and menthol lozenges as these are equally effective and safer 7
  • Codeine-containing products should never be used for URI-related cough as they lack efficacy and increase adverse effects 1, 9
  • Cough due to asthma requires treatment of underlying asthma with inhaled corticosteroids and bronchodilators, not cough suppressants 7

Safety Profile

  • Dextromethorphan adverse reactions are infrequent and usually not severe, with dose-related neurological, cardiovascular, and gastrointestinal symptoms 6
  • The safety profile is reassuring for short-term treatment, with no clinically significant risk from pharmacokinetic polymorphism (CYP2D6 poor metabolizers) when used appropriately 2, 6
  • Abuse represents the most significant safety hazard identified in adverse event reporting 6

Red Flags Requiring Immediate Evaluation

  • Cough persisting >3 weeks requires discontinuation of antitussive therapy and comprehensive diagnostic work-up 1
  • Hemoptysis, significant dyspnea, fever with purulent sputum, or clinical deterioration warrant immediate emergency evaluation 1
  • Development of more than mild symptoms (beyond infrequent vomiting or light somnolence) after ingestion requires emergency department referral 5

References

Guideline

Guideline Recommendations for Cough Management in Influenza

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Life-threatening pediatric dextromethorphan polistirex overdose.

The American journal of emergency medicine, 2022

Guideline

Cough Management Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guidelines for Codeine Use in Cough Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.